Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

MedTainer Orders Continue to Grow; More LPs Choosing Acology


Posted on: 23 Jul 18

CORONA, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that orders for its signature product, the MedTainer™, continue to increase beyond the record pace set for the same quarter last year. In addition, more Licensed Producers have begun to order what Acology has positioned as one of the primary, if not THE primary, retail packaging containers for the emerging cannabis market. In addition, one of Canada’s premier franchising companies, the Shefield Group, has begun a pilot program to introduce the MedTainer to its customers across the country. Both Acology and Shefield agree that retail cannabis will be a major market in Canada and that hundreds, if not thousands of stores, shops and boutiques will soon be selling cannabis products to the general consumer. The franchise sector in Canada currently generates over $68B in retail sales per year.

With legislation decided, and packaging rules now in effect throughout the country, Acology has begun manufacturing Canada-specific packaging with proper labels, child-resistant lids and two-way humidity packs in each MedTainer. Acology has focused on becoming the standard packaging system for across-the-counter, pre-packaged cannabis sales in North America. The MedTainer’s unique design, FDA-approved #5 polypropylene construction material, certified child-resistant caps and MedX 2-way humidity packs put the product in a class by itself.

Acology has also vigorously and successfully defended its intellectual property from counterfeiters in China. There are currently no restrictions on what chemicals are used in the manufacturing processes of Chinese products that come into the country. Plastics, ceramics, glass and paper products manufactured in North America and which are strictly controlled and monitored have no such restrictions in China. An alarming number of cases have been reported that plastics containing BPA (Bisphenol A) have made it to Canadian shores and are now being sold to consumers ahead of the regulatory process agreed on through Parliament. In part, this was one of the primary reasons that Acology acquired all the MedTainer intellectual property this past April. Acology feels that it’s extremely important to protect their customers’ health. The experience that one has with cannabis should be safe and pleasurable. Acology, by continuing to make the MedTainer available to as wide a market as possible, is doing just that.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director.  Acology can also be accessed through Twitter and Instagram at @Acologyinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cd57337d-870b-42fe-8a8d-81bc3226adba

GlobeNewswire
globenewswire.com

Last updated on: 23/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.